CardioFuture

MedTech, Cardio, Dental and OrthoFuture blog pages help you stay on top of the latest news in the medical device industries.

Helping you stay on top of the latest developments in the cardiovascular industry.

MedTech, Cardio, Dental and OrthoFuture blog pages help you stay on top of the latest news in the medical device industries.

Helping you stay on top of the latest developments in the cardiovascular industry.

Stay Up-to-Date with our Monthly CardioFuture Newsletter

SUBSCRIBE

Stay Up-to-Date with our Monthly CardioFuture Newsletter

SUBSCRIBE
COVID-19 Causes a Significant Drop in Interventional Cardiology Procedure Numbers
Cardiology, COVID-19, Interventional Cardiology

COVID-19 Causes Significant Drop in Interventional Cardiology Procedure Numbers

September 25, 2020
Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. These procedures allow the heart to continue functioning at its best moving almost 3,000 gallons of blood every day. Based on the European Heart Journal, cardiovascular disease (CVD)......
Investigational Intrepid™ Transcatheter Valve System
Cardiac Surgery, Cardiology

FDA Grants Medtronic Breakthrough Device Designation for Transcatheter Valve System

September 17, 2020
The FDA Breakthrough Devices Program enables manufacturers to streamline the market clearance/approval process for specific medical devices. Medtronic received the breakthrough device designation for its investigational Intrepid™ transcatheter tricuspid valve replacement (TTVR) system. The FDA has also approved an early feasibility study for the device. The new TTVR system will help treat tricuspid valve regurgitation,......
Fitbit Used to Track COVID-19 Symptoms Remotely
Cardiac Rhythm Management, COVID-19, Diagnostics, Patient Monitoring

Fitbit Used for Early Detection of COVID-19 Symptoms

August 28, 2020
Currently, the demand for healthcare workers and facilities is extraordinarily high in areas heavily affected by COVID-19. The demand for patient monitoring devices is also high. One of the biggest challenges in reducing the spread of the virus is contact tracing, which is made difficult through a high demand for health personnel, and because of......
Philips Launches Two Portable Biomedical Products In US
Cardiac Rhythm Management, Cardiology, Diagnostics, Interventional Cardiology, Patient Monitoring

Philips Launches Two Portable Biomedical Products In US

August 7, 2020
Philips has announced the launch of two portable biomedical products, after obtaining FDA approval for them: the Tempus ALS and Tempus Pro. Both of the devices are designed for use with Philips’ Intellispace Corsium software. This web-based platform is used to record and upload data real-time, and it can be used for communication. This adds......
New Cardiac Monitor Using Nanogenerators Powered by Human Body
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

New Cardiac Monitor Uses Nanogenerators Powered by Human Body

August 6, 2020
Researchers at Purdue University have been developing a wearable cardiac monitor that functions by harvesting the energy of the human body. The device uses TENG’s, triboelectric nanogenerators, with polyvinyl alcohol-based contact layers, to monitor cardiac health. If further research shows this technology is viable, this could be a major step forward for all patient monitoring......
Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms

August 5, 2020
The FDA has granted Emergency Use Authorization to Abiomed for their left-sided Impella heart pumps. These pumps are used to support patients during heart failure and provide left ventricular unloading. The long-term effects of COVID-19 are not yet well-understood. Initially, the most focus was placed on respiratory issues and lung damage, which were the most......
Boston Scientific Granted FDA Approval for Stroke Prevention Device
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

Boston Scientific Granted FDA Approval for Stroke Prevention Device

August 4, 2020
According to iData’s latest Interventional Cardiology market report, Boston Scientific is the leading competitor in this market. Now, they have produced another innovative interventional cardiology device. The FDA has recently approved Boston Scientific’s stroke prevention device, the Watchman FLX, making it available for sale in the US. This device follows the original edition of the......
Medtronic receives CE mark for Micra AV Pacemaker
Cardiac Rhythm Management, Cardiology, Diagnostics, Interventional Cardiology, Patient Monitoring

Medtronic receives CE mark for Micra AV Pacemaker

July 8, 2020
Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaired neural signals between atrial and ventricular chambers in the heart. AV block can lead to irregular beat, and in some cases, increased risk......
Boston Scientific Given FDA 510(k) Clearance for Insertable Cardiac Monitor System
Cardiac Rhythm Management, Cardiology, Diagnostics, Patient Monitoring

Boston Scientific Given FDA 510(k) Clearance for Insertable Cardiac Monitor System

July 8, 2020
Boston Scientific has been granted FDA 510(k) clearance for their LUX-Dx insertable cardiac monitor system. This long-term diagnostic device is used to detect arrhythmias from conditions such as atrial fibrillation, syncope, and cryptogenic stroke. The LUX-Dx’s multi-stage algorithm first detects potential arrhythmias, then verifies them. When an arrhythmia is verified, clinicians are immediately alerted, so......
Articles, Atherectomy, Cardiology, COVID-19 Industry Insights, Peripheral Vascular

Atherectomy Market is Heating Up: Strong Growth and Increasing Competition

July 6, 2020
According to the latest market analysis by iData Research, the U.S. atherectomy market is expected to remain as one of the biggest contributors to the growth of the peripheral vascular market. While often performed in conjunction with other procedures, such as angioplasties, atherectomy procedures have been experiencing double-digit growth rates for the past two years......
Lithotripsy Procedure Equipment
Articles, Cardiology, COVID-19 Industry Insights, Lithotripsy, Peripheral Vascular

Over 24,000 Intravascular Lithotripsy Procedures to be Performed by 2026 in the US

July 3, 2020
According to the latest market analysis by iData Research, there are over 12,000 intravascular lithotripsy procedures performed in the United States every year. This number is expected to experience incredible growth and double in number by 2026. This growth can be attributed to two main factors: the creation of procedure codes by CMS, and successful......
FDA Grants Emergency Use Authorization for Abiomed Impella RP
Cardiac Surgery, Cardiology, COVID-19, Interventional Cardiology

FDA Grants Emergency Use Authorization to Abiomed for Impella RP

June 5, 2020
Abiomed has been granted FDA emergency use authorization for its Impella RP – a temporary heart pump to support circulatory system functioning in patients with right side ventricular failure. The FDA has granted EUA for this device to treat COVID-19 patients, as some of them have suffered from right heart failure due to the virus,......
Articles, Cardiology, COVID-19 Industry Insights, Vascular Access

Over 2.7 million PICC line insertion procedures are performed each year in the United States

June 2, 2020
According to the latest vascular access device and accessories market analysis by iData Research, there are over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year in the United States. The overall US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026.......
US Vascular Access Catheter and Accessories markets
Articles, Cardiology, COVID-19 Industry Insights, Vascular Access

PICC, CVC, and PIVC insertion accessories are driving market growth in the United States

May 28, 2020
According to the latest market analysis by iData Research, the US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. One of the biggest contributors to this growth will be the PICC, CVC, and PIVC line insertion and securement accessories market. This market growth is primarily......
Terumo Aortic gains FDA breakthrough status for new aortic repair device
Cardiac Surgery, Cardiology, Interventional Cardiology

Terumo Aortic Gains FDA Breakthrough Status for Aortic Repair Device

May 6, 2020
Terumo Aortic, a company that focuses exclusively on producing devices regarding aorta, has developed the Thoraflex Hybrid to aid patients who have suffered from a thoracic aortic aneurysm, or a tear in the aortic vessel wall. These conditions are often fatal, and have low survival rates, even when patients receive prompt medical care. The device......
Lungpacer Medical gains FDA approval for diaphragm pacer therapy system
Cardiology, COVID-19, Respiratory Devices

Lungpacer Medical Gains FDA Approval for Diaphragm Pacer

May 5, 2020
Vancouver-based company Lungpacer Medical has developed a single-use multi-electrode stimulating catheter that is inserted into the left subclavicle vein. It is used to stimulate the left and right phrenic nerves, providing support to the functioning of the diaphragm in patients who have respiratory issues. The device is paired with an external, reusable control unit to......
CMS Recommends Reopening Healthcare in Areas of Low COVID-19 Cases
Cardiology, COVID-19, Dental, Endoscopy, Orthopedics

CMS Recommends Reopening Healthcare in Areas of Low COVID-19 Cases

April 21, 2020
The Center for Medicare and Medicaid Services (CMS) is reissuing new guidelines for states and regions seeing declining and stabilizing COVID-19 infection rates and recommending healthcare facilities in these areas to resume providing elective procedures to patients without COVID-19 symptoms. On March 18, 2020, the CMS announced they would postponing non-essential medical and surgical procedures......
Q&A with an Analyst: Vascular Access Market
Cardiology, COVID-19 Industry Insights, Vascular Access

Q&A with an Analyst: Vascular Access Market

April 16, 2020
Welcome to the analyst interview series where we take a closer look at specific markets and try to understand how they are being impacted by the COVID-19 virus. Through asking our market analysts a series of questions, we attempt to get an in-depth look at the current state of the market while uncovering critical market......
BardyDx Patch Monitors Coronavirus Patients Prescribed HCQ Experimentally
Cardiac Rhythm Management, Cardiology, COVID-19, Patient Monitoring

Bardy Dx Patch Monitors Coronavirus Patients Prescribed HCQ

April 1, 2020
Bardy Diagnostics‘ Carnation Ambulatory Monitor (CAM™) Patch is being used by Seattle health care workers to monitor heart beat and measure QT segments in coronavirus patients prescribed HCQ experimentally. HCQ was recently authorized to treat coronavirus patients by the FDA under the Emergency Use Authorization. HCQ is commonly used to treat malaria, lupus and rheumatoid......
ACE-I and ARBs Do Not Increase COVID-19 Mortality
Cardiology, COVID-19

ACE-I and ARBs Do Not Increase COVID-19 Mortality

March 25, 2020
CMS Postponing Non-Essential Medical, Surgical, and Dental Procedures The European Society of Cardiology (ESC), the American Heart Association (AHA), the Heart Failure Society of American (HFSA) and American College of Cardiology (ACC) have issued official statements clarifying that ACE-i and ARBs have not been found to increase COVID-19 mortality rates. Physicians are recommending coronavirus patients......
CMS Recommends Postponing Non-Essential Medical, Surgical, and Dental Procedures
Cardiology, COVID-19, Dental, Endoscopy, Industry News, Orthopedics

CMS Postponing Non-Essential Medical, Surgical, and Dental Procedures

March 24, 2020
CMS Postponing Non-Essential Medical, Surgical, and Dental ProceduresAt the White House Task Force Press Briefing last week, the Center for Medicare & Medicaid Services (CMS) announced that all non-essential medical, surgical and dental procedures would be postponed until further notice in order to shift priorities to treating those affected by the coronavirus outbreak. The decision......
Cardiac Rhythm Management, Cardiology, Patient Monitoring

AI Predicts Heart Failure Hospitalization up to 10 Days in Advance

March 4, 2020
AI Predicts Heart Failure Hospitalization up to 10 Days in Advance PhysIQ and U.S. Veteran’s Affairs have published successful clinical trial results showing how artificial intelligence (AI) can be used to predict heart failure hospitalization up to 10 days in advance. The study, published in Circulation: Heart Failure, assesses PhysIQ’s pinpointIQ™ continuous data collection and......
Artificial Tissue Patches Mimic Heart Tissue to Heal Heart Damage
Cardiac Surgery, Cardiology

Artificial Tissue Patches Help Heal Heart Damage

February 26, 2020
Bioengineers at Trinity College Dublin have engineered artificial tissue patches that imitate the natural electrical conductivity of heart tissue while being structurally designed to withstand the movement of a beating heart. In addition to improving electrical signalling throughout the heart, the patches promote new cell growth and development to help heal damaged heart cells. The......
aortic_aneurysm
Articles, Cardiology

NICE Draft Guidelines To Disrupt The Fenestrated Stent Graft Market

February 19, 2020
Overview Over the past decade, endovascular aortic repair (EVAR) has become the dominant technique for treatment, composing over 77% of aortic repairs in 2019. Developed in 1990, this procedure has undergone drastic changes in efficacy over the past decade due to advancements in graft technology and manufacturing techniques. The employment of computerized tomography (CT) scans......
FDA authorizes use of Caption Health’s AI software to capture heart images via ultrasound
Cardiology, Medical Imaging, Ultrasound Imaging

FDA Approves AI Software to Capture Heart Images Via Ultrasound

February 12, 2020
The FDA has announced approval and authorization of Caption Health‘s AI software, Caption Guidance, to analyze and assist with cardiac ultrasounds (echocardiography). Heart disease kills approximately one out of every four Americans each year according to the Center for Disease Control and Prevention. Electrocardiograms (ECGs), Holter monitors and echocardiograms are most commonly used to identify......
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link

close-link